Literature DB >> 8806072

Domains of laminin.

E Engvall1, U M Wewer.   

Abstract

Extracellular matrix molecules are often very large and made up of several independent domains, frequently with autonomous activities. Laminin is no exception. A number of globular and rod-like domains can be identified in laminin and its isoforms by sequence analysis as well as by electron microscopy. Here we present the structure-function relations in laminins by examination of their individual domains. This approach to viewing laminin is based on recent results from several laboratories. First, some mutations in laminin genes that cause disease have affected single laminin domains, and some laminin isoforms lack particular domains. These mutants and isoforms are informative with regard to the activities of the mutated and missing domains. These mutants and isoforms are informative with regard to the activities of the mutated and missing domains. Second, laminin-like domains have now been found in a number of other proteins, and data on these proteins may be informative in terms of structure-function relationships in laminin. Finally, a large body of data has accumulated on the structure and activities of proteolytic fragments, recombinant fragments, and synthetic peptides from laminin. The proposed activities of these domains can now be confirmed and extended by in vivo experiments.

Mesh:

Substances:

Year:  1996        PMID: 8806072     DOI: 10.1002/(SICI)1097-4644(19960616)61:4%3C493::AID-JCB2%3E3.0.CO;2-J

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  26 in total

1.  A novel cell binding site in the coiled-coil domain of laminin involved in capillary morphogenesis.

Authors:  Laura Sanz; Laura García-Bermejo; Francisco J Blanco; Peter Kristensen; Mónica Feijóo; Eduardo Suárez; Belén Blanco; Luis Alvarez-Vallina
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

2.  Laminin-10 is crucial for hair morphogenesis.

Authors:  Jie Li; Julia Tzu; Yi Chen; Yan-Ping Zhang; Ngon T Nguyen; Jing Gao; Maria Bradley; Douglas R Keene; Anthony E Oro; Jeffrey H Miner; M Peter Marinkovich
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

Review 3.  Physiological and pathological roles of alpha3beta1 integrin.

Authors:  Tsutomu Tsuji
Journal:  J Membr Biol       Date:  2004-08-01       Impact factor: 1.843

4.  Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions.

Authors:  Jie Li; Lisa Zhou; Hoang T Tran; Yi Chen; Ngon E Nguyen; Marvin A Karasek; M Peter Marinkovich
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

5.  Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.

Authors:  P H Vachon; H Xu; L Liu; F Loechel; Y Hayashi; K Arahata; J C Reed; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  Three heterotrimeric laminins produced by human keratinocytes.

Authors:  C Kumagai; M Okano; Y Kitagawa
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

Review 7.  Integrins and vascular extracellular matrix assembly.

Authors:  E Ruoslahti; E Engvall
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

8.  The alpha chain of laminin-1 is independently secreted and drives secretion of its beta- and gamma-chain partners.

Authors:  P D Yurchenco; Y Quan; H Colognato; T Mathus; D Harrison; Y Yamada; J J O'Rear
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

9.  Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.

Authors:  W Kuang; H Xu; P H Vachon; L Liu; F Loechel; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  Endothelial cell-laminin interaction: modulation of LDH expression involves alpha6beta4 integrin-FAK-p38MAPK pathway.

Authors:  P R Sudhakaran; R I Viji; M S Kiran; V B Sameer Kumar
Journal:  Glycoconj J       Date:  2008-09-24       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.